Fu, An
Ge, Feng
Wang, Yanwei
Guo, Haili
Zhu, Man
Li, Shu
Gao, Ao
Li, Chao
Lu, Jingchuan
Guo, Daihong
Funding for this research was provided by:
a confidential project (17CXZ010)
a confidential project (17CXZ010)
a confidential project (17CXZ010)
a confidential project (17CXZ010)
a confidential project (17CXZ010)
a confidential project (17CXZ010)
a confidential project (17CXZ010)
a confidential project (17CXZ010)
a confidential project (17CXZ010)
a confidential project (17CXZ010)
the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs commissioned by the Chinese Association of Research Hospitals (Y2023FH-YWPJ03)
the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs commissioned by the Chinese Association of Research Hospitals (Y2023FH-YWPJ03)
the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs commissioned by the Chinese Association of Research Hospitals (Y2023FH-YWPJ03)
the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs commissioned by the Chinese Association of Research Hospitals (Y2023FH-YWPJ03)
the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs commissioned by the Chinese Association of Research Hospitals (Y2023FH-YWPJ03)
the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs commissioned by the Chinese Association of Research Hospitals (Y2023FH-YWPJ03)
the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs commissioned by the Chinese Association of Research Hospitals (Y2023FH-YWPJ03)
the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs commissioned by the Chinese Association of Research Hospitals (Y2023FH-YWPJ03)
the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs commissioned by the Chinese Association of Research Hospitals (Y2023FH-YWPJ03)
the Project of Monitoring and Evaluation of the Use of Key Clinical Drugs commissioned by the Chinese Association of Research Hospitals (Y2023FH-YWPJ03)
Article History
Received: 31 July 2023
Accepted: 24 June 2024
First Online: 12 July 2024
Declarations
:
: This study involving humans was approved by the Ethics Committee of Chinese PLA General Hospital with a waiver of the requirement for informed consent (S2018-054-01).
: Not applicable.
: The authors declare no competing interests.